Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

• Utah Governor Spencer Cox opens 190,000-square-foot building
  
• Nusano platform capable of producing more than 40 different radioisotopes for healthcare and industry
  
• New supplies of radioisotopes urgently needed for new and emerging cancer diagnostics and therapeutics
  
• Reservations and supply agreements underway for production beginning late 2025

WEST VALLEY CITY, Utah, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today cut the ribbon on its 190,000-square-foot radioisotope production facility. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications, such as long-lived nuclear batteries.

On hand to help cut the ribbon was Utah Governor Spencer Cox. Surrounded by company employees, business and community leaders, Gov. Cox proclaimed the event as emblematic of the state’s continued leadership in life sciences and advanced manufacturing.

“Utah has always been a place where bold ideas take root, and Nusano’s new facility is a perfect example,” said Gov. Cox. “This work will deliver the radioisotopes needed for cancer treatment, advanced technologies, and national security. We’re incredibly proud to have another true pioneer in our innovation economy.”

Nusano combines time-proven technology from universities and world-class research centers with the company’s patented particle acceleration technology. The result is the first significant advancement in radioisotope production in decades – a highly efficient linear accelerator-based platform capable of simultaneous manufacturing of multiple radioisotopes needed across a variety of industries.

“Nusano is commercializing breakthrough technologies to enable innovation, improve human health, and power exploration,” said Chris Lowe, CEO of Nusano. “From our world class production facility in Utah, we will make radioisotopes in quantities and varieties unsurpassed by older methods. This will help address supply chain bottlenecks, support domestic manufacturing, and deliver life-changing radioisotope supplies needed for cancer care.”

Supply agreements and reservations for Nusano’s radioisotope production are underway. Organizations interested in ordering samples and securing radioisotope supplies should contact sales@nusano.com.

Supplying the fight against cancer

Radioisotopes are essential components in the active pharmaceutical ingredients (API) of new and emerging cancer treatments known as radiopharmaceuticals. Existing medical radioisotope supply chains are often strained, posing a risk to patient care, clinical trials, and ongoing drug development. Nusano is working to address these shortages and deliver new radioisotope supplies so additional therapeutic approaches can be explored.

“Today, researchers and drugmakers are working with what’s available, not necessarily what’s optimal,” said Dr. Howard Lewin, co-founder and Chief Product Development Officer of Nusano. “Our Utah facility can produce up to 12 different radioisotopes simultaneously. This means we can meet the existing needs of drugmakers and at the same time enable tomorrow’s clinical breakthroughs with isotopes that would be unavailable or hard to access without Nusano’s production.”

Powering advanced applications

Beyond healthcare, radioisotopes have applications across a variety of industries, including advanced aerospace and defense technologies. One such use is long-lived batteries powered by radioisotopes, known as nuclear batteries.

Ideally suited for nuclear batteries is a class of radioisotopes known as alpha-emitters, which Nusano can produce at scale. The long half-life of certain alpha-emitting radioisotopes produces steady, dependable sources of energy. This can equate to a multi-year battery lifespan, depending on the isotope selected. Alpha-emitters also offer low-penetration radiation, which reduces shielding requirements, enabling compact, durable battery designs that can often be placed directly onto the computer chip powered by the battery.

“Nuclear batteries are always-on systems built to provide power in places where it would be inconvenient or impossible to routinely swap out traditional batteries, such as remote ocean sensors or space satellites,” said Glenn Rosenthal, co-founder and Chief Technology Officer of Nusano. “The longevity and efficiency of nuclear batteries has the potential to redefine how connected devices are powered in ways that will improve modern logistics and enable the continued exploration of our universe.”

About the Nusano Radioisotope Production Platform
The Nusano production platform enables the simultaneous production of a wide variety of radioisotopes at unprecedented quantities. The process begins with Nusano’s patented ion source. The company’s foundational technology, the source creates heavy ions at rates hundreds of times greater than existing commercial systems. The ability to create and accelerate heavy ions is what enables Nusano’s breakthrough production volumes. Videos detailing the unique capabilities of the Nusano production platform are available at https://nusano.link/tech-overview.

About Nusano
Nusano is a privately held physics company working to stabilize supply chains, advance American national security by reducing dependency on foreign supply, and enable once-in-a-generation innovations in fields ranging from healthcare to nuclear energy. The company is commercializing platform technologies for radioisotope production, stable isotope enrichment, and advanced separation techniques. Together, these proprietary systems and methods are poised to supply the fight against cancer, fuel the nuclear renaissance, and deliver critical minerals for the modern world. For more, visit nusano.com. 

Contacts:

• Media: Scott Larrivee, Nusano, 608-345-6629, scott.larrivee@nusano.com
• Investor Relations: Joyce Allaire, LifeSci Advisors, LLC, 212-915-2569, jallaire@lifesciadvisors.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f4750722-b435-4fae-a1d0-4d292bd94213

Nusano Ribbon Cutting Ceremony

Pictured (L-R):Howard Lewin, Nusano co-founder & Chief Product Development Officer; Glenn Rosenthal, Nusano co-founder & Chief Technology Officer; Chris Lowe, Nusano CEO; John Dahlstrom, EVP, Wastach Group; and Utah Gov. Spencer Cox.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.